{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:05:10Z","timestamp":1785323110484,"version":"3.55.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Breast-conserving therapy (BCT) in BRCA-associated breast cancer remains a subject of ongoing debate, primarily due to concerns regarding local recurrence and the development of second primary tumors. This review provides a critical appraisal of the current evidence comparing BCT and mastectomy, integrating oncologic outcomes with biological insights and patient-centered perspectives. Evidence from cohort studies and meta-analyses indicates that, although BCT is associated with a higher incidence of ipsilateral breast events, this does not translate into inferior long-term survival. This apparent divergence may reflect the distinct biological profile of BRCA-associated tumors, characterized by impaired DNA repair mechanisms and increased responsiveness to systemic treatments, which may enhance therapeutic efficacy, particularly in the neoadjuvant setting. Recent advances in systemic therapies, including PARP inhibitors, along with improvements in radiotherapy and imaging, have broadened the clinical applicability of breast-conserving strategies. Furthermore, considerations related to quality of life and patient preferences reinforce the importance of individualized surgical planning. In this context, BCT can be considered a valid and oncologically sound option for selected BRCA mutation carriers, supporting a tailored multidisciplinary approach to treatment decision-making.<\/jats:p>","DOI":"10.3389\/fonc.2026.1861028","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:40:58Z","timestamp":1785321658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The increasing role of breast-conserving treatment in patients with BRCA-related breast cancer: an appraisal of recent literature"],"prefix":"10.3389","volume":"16","author":[{"given":"Alessandro","family":"Fancellu","sequence":"first","affiliation":[{"name":"Breast Unit, Azienda Ospedaliero-Universitaria di Sassari","place":["Sassari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Giuliani","sequence":"additional","affiliation":[{"name":"Breast Unit, Azienda Ospedaliero-Universitaria di Sassari","place":["Sassari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mulas","sequence":"additional","affiliation":[{"name":"Breast Unit, Azienda Ospedaliero-Universitaria di Sassari","place":["Sassari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Contini","sequence":"additional","affiliation":[{"name":"Breast Unit, Azienda Ospedaliero-Universitaria di Sassari","place":["Sassari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Ariu","sequence":"additional","affiliation":[{"name":"Breast Unit, Azienda Ospedaliero-Universitaria di Sassari","place":["Sassari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Piredda","sequence":"additional","affiliation":[{"name":"Breast Unit, Azienda Ospedaliero-Universitaria di Sassari","place":["Sassari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Sanna","sequence":"additional","affiliation":[{"name":"Dept. of Medical Oncology, Azienda Ospedaliero-Universitaria di Sassari","place":["Sassari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181d38f2f","article-title":"Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2","volume":"12","author":"Petrucelli","year":"2010","journal-title":"Genet Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-020-01148-2","article-title":"Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis","volume":"28","author":"Yoshida","year":"2021","journal-title":"Breast Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2019.22.e47","article-title":"Contralateral breast cancer and ipsilateral breast tumor recurrence in BRCA1\/2 carriers and non-carriers at high risk of hereditary breast cancer","volume":"22","author":"Yoon","year":"2019","journal-title":"J Breast Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0638-7","article-title":"Breast-conserving surgery in BRCA1\/2 mutation carriers: are we approaching an answer","volume":"16","author":"Garcia-Etienne","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/life15111701","article-title":"Breast-conserving surgery in BRCA mutation carriers: a paradigm shift toward individualized, multidisciplinary care","volume":"15","author":"Cipolla","year":"2025","journal-title":"Life (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2019.07.014","article-title":"Breast conserving surgery for BRCA mutation carriers\u2014a systematic review","volume":"20","author":"Co","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znab145","article-title":"Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis","volume":"108","author":"Fancellu","year":"2021","journal-title":"Br J Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.7019","article-title":"Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy","volume":"28","author":"Byrski","year":"2010","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.02.010","article-title":"Platinum-based neoadjuvant chemotherapy in BRCA-mutated breast cancer: a systematic review and meta-analysis","volume":"167","author":"Jia","year":"2022","journal-title":"Eur J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.7888","article-title":"Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer","volume":"24","author":"Pierce","year":"2006","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-1336-7","article-title":"Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"127","author":"Metcalfe","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials","volume":"378","year":"2011","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Peto","year":"2012","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3115-3","article-title":"High risk of in-breast tumor recurrence after BRCA1\/2-associated breast cancer","volume":"147","author":"Nilsson","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.04.024","article-title":"Surgical management of BRCA-mutation carriers: a single institution experience","volume":"48","author":"Gentile","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.9840","article-title":"Long-term oncologic outcome of breast-conserving treatment in patients with breast cancer with BRCA variants","volume":"8","author":"Lee","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11756-1","article-title":"Comparison of outcomes between BRCA pathogenic variant carriers undergoing breast-conserving surgery versus mastectomy","volume":"29","author":"Shubeck","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2024.102760","article-title":"Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment","volume":"53","author":"Mahiou","year":"2024","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2836","article-title":"Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation","volume":"9","author":"Ye","year":"2020","journal-title":"Cancer Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.18486","article-title":"Clinical outcomes for BRCA pathogenic variant carriers with breast cancer undergoing breast conservation","volume":"7","author":"Wanis","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002804","article-title":"Prognostic impact of breast-conserving therapy versus mastectomy of BRCA1\/2 mutation carriers compared with noncarriers in a consecutive series of young breast cancer patients","volume":"270","author":"van den Broek","year":"2019","journal-title":"Ann Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5691.22.09820-3","article-title":"Breast-conserving therapy leads to better survival outcomes compared to mastectomy in patients with early breast cancer: evidences from the recent literature","volume":"78","author":"Fancellu","year":"2023","journal-title":"Minerva Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-2890-1","article-title":"Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis","volume":"144","author":"Valachis","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.breast.2021.02.001","article-title":"Combined breast conservation therapy versus mastectomy for BRCA mutation carriers\u2014a systematic review and meta-analysis","volume":"56","author":"Davey","year":"2021","journal-title":"Breast"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-021-01312-2","article-title":"Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis","volume":"29","author":"Wang","year":"2022","journal-title":"Breast Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12282-022-01343-3","article-title":"Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis","volume":"29","author":"Nara","year":"2022","journal-title":"Breast Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0009-7","article-title":"Carboplatin in BRCA1\/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT trial","volume":"24","author":"Tutt","year":"2018","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/cncr.20728","article-title":"Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series","volume":"103","author":"Robson","year":"2005","journal-title":"Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2022.01.002","article-title":"An overview on radiation sensitivity in hereditary breast cancer","volume":"62","author":"Gon\u00e7alves","year":"2022","journal-title":"Breast"},{"key":"B34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10549-012-2349-1","article-title":"The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis","volume":"137","author":"Fang","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24364","article-title":"Patient satisfaction with nipple-sparing mastectomy: A prospective study of patient reported outcomes using the BREAST-Q","volume":"114","author":"Howard","year":"2016","journal-title":"J Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002748.pub3","article-title":"Prophylactic mastectomy for the prevention of breast cancer","volume":"11","author":"Lostumbo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181e623db","article-title":"A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient-reported outcome measures and health-related quality of life","volume":"252","author":"Winters","year":"2010","journal-title":"Ann Surg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e31829586a7","article-title":"Quality-of-life outcomes between mastectomy alone and breast reconstruction: comparison of patient-reported BREAST-Q and other health-related quality-of-life measures","volume":"132","author":"Eltahir","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1037\/a0014778","article-title":"Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review","volume":"28","author":"Hamilton","year":"2009","journal-title":"Health Psychol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7076.281","article-title":"Women\u2019s need for information before attending genetic counselling for familial breast or ovarian cancer: a qualitative study","volume":"314","author":"Hallowell","year":"1997","journal-title":"BMJ"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.0631","article-title":"Long-term quality of life in patients with breast cancer after breast conservation vs mastectomy and reconstruction","volume":"157","author":"Hanson","year":"2022","journal-title":"JAMA Surg"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-022-01178-z","article-title":"Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance","volume":"17","author":"Ankersmid","year":"2023","journal-title":"J Cancer Surviv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00299","article-title":"Management of hereditary breast cancer: ASCO, ASTRO, and SSO guideline","volume":"38","author":"Tung","year":"2020","journal-title":"J Clin Oncol"},{"key":"B45","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Breast Cancer\n          \n          \n          \n          2026"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-024-01759-w","article-title":"The importance of the multidisciplinary team in the decision-making process of patients undergoing neoadjuvant chemotherapy for breast cancer","volume":"76","author":"Fancellu","year":"2024","journal-title":"Updates Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.574813","article-title":"Insights into the impacts of BRCA mutations on clinicopathology and management of early-onset triple-negative breast cancer","volume":"10","author":"Ye","year":"2021","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1861028\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:40:59Z","timestamp":1785321659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1861028\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":48,"alternative-id":["10.3389\/fonc.2026.1861028"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1861028","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1861028"}}